OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 139 citing articles:

Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
Artemiy Silantyev, Luca Falzone, Massimo Libra, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 863-863
Open Access | Times Cited: 208

Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk
Amanda McQuade, Mathew Blurton‐Jones
Journal of Molecular Biology (2019) Vol. 431, Iss. 9, pp. 1805-1817
Open Access | Times Cited: 198

Extracellular Vesicle-Mediated Cell–Cell Communication in the Nervous System: Focus on Neurological Diseases
Celeste Caruso Bavisotto, Federica Scalia, Antonella Marino, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 434-434
Open Access | Times Cited: 135

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis
Jiaying Wang, Jiajia Wang, Jincheng Wang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 127

Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application
Serena Silvestro, Placido Bramanti, Emanuela Mazzon
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3979-3979
Open Access | Times Cited: 100

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
Agnese Gugliandolo, Federica Pollastro, Gianpaolo Grassi, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1992-1992
Open Access | Times Cited: 90

Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
Andrew R. Clark, Michael Ohlmeyer
Pharmacology & Therapeutics (2019) Vol. 201, pp. 181-201
Open Access | Times Cited: 84

A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME/CFS
Angus Mackay
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 82

The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease
Saverio Candido, Gabriella Lupo, Manuela Pennisi, et al.
Oncology Reports (2019)
Open Access | Times Cited: 81

Plasticity of microglia
Marcus Augusto‐Oliveira, Gabriela de Paula Arrifano, Charlotte Delage, et al.
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2021) Vol. 97, Iss. 1, pp. 217-250
Closed Access | Times Cited: 78

Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Doortje Dekens, Ulrich Eisel, Leonie Gouweleeuw, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101414-101414
Open Access | Times Cited: 62

A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis
Hila Doron, Tobias Pukrop, Neta Erez
Cancer Research (2019) Vol. 79, Iss. 3, pp. 423-436
Open Access | Times Cited: 75

Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
Santa Mammana, Eugenio Cavalli, Agnese Gugliandolo, et al.
Medicina (2019) Vol. 55, Iss. 11, pp. 747-747
Open Access | Times Cited: 74

Genetic polymorphisms as determinants of pesticide toxicity: Recent advances
Michele Teodoro, Giusi Briguglio, Concettina Fenga, et al.
Toxicology Reports (2019) Vol. 6, pp. 564-570
Open Access | Times Cited: 72

Microglial NLRP3 inflammasome activation in multiple sclerosis
Melis Olcum, Bora Tastan, Cagla Kiser, et al.
Advances in protein chemistry and structural biology (2019), pp. 247-308
Closed Access | Times Cited: 69

Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial
William Camu, Marius Mickunas, Jean‐Luc Veyrune, et al.
EBioMedicine (2020) Vol. 59, pp. 102844-102844
Open Access | Times Cited: 67

Vascular Risk Factors and Alzheimer’s Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links
Jinting He, Xin Zhao, Lei Xu, et al.
Journal of Alzheimer s Disease (2019) Vol. 73, Iss. 1, pp. 39-58
Closed Access | Times Cited: 65

Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain
Gloria Donninelli, Inbar Saraf‐Sinik, Valentina Mazziotti, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 61

Neutrophils Return to Bloodstream Through the Brain Blood Vessel After Crosstalk With Microglia During LPS-Induced Neuroinflammation
Yu Rim Kim, Young Min Kim, Jaeho Lee, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 57

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
Usma Munawara, Michael Catanzaro, Weili Xu, et al.
Immunity & Ageing (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 56

Role of Peripheral Immune Cells-Mediated Inflammation on the Process of Neurodegenerative Diseases
Qiuyu Yang, Guoqing Wang, Feng Zhang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 53

Moringa oleifera: A Tree of Life as a Promising Medicinal Plant for Neurodegenerative Diseases
Saurav Ghimire, Lalita Subedi, Namrata Acharya, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 48, pp. 14358-14371
Closed Access | Times Cited: 47

Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases
Subhashini Brahadeeswaran, Narmadhaa Sivagurunathan, Calivarathan Latchoumycandane
Molecular Neurobiology (2022) Vol. 59, Iss. 4, pp. 2288-2304
Closed Access | Times Cited: 38

Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?
Serena Silvestro, Andrea Valeri, Emanuela Mazzon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2011-2011
Open Access | Times Cited: 29

Page 1 - Next Page

Scroll to top